Objectives: To determine the current antimicrobial sensitivity profile of MRSA and compare it with the antimicrobial sensitivity of MSSA (Methicillin Sensitive Staphylococcus aureus) Material and Methods: Antimicrobial resistance in Staphylococcus aureus is a global public health concern. Methicillin-resistant Staphylococcus aureus (MRSA) is often resistant to the many classes of antibiotics compared to the methicillin-sensitive Staphylococcus aureus (MSSA). Five hundred and fifty S. aureus isolates obtained from clinical samples of pediatric patients were studied to determine the difference in the antimicrobial susceptibility between MRSA and MSSA. Results: Out of 550 S. aureus isolates, 59.3% were MSSA, and 40.7% were MRSA. The antimicrobial sensitivity to ciprofloxacin, gentamicin, clindamycin, erythomycin, tetracycline of MSSA was 26.4% , 93.6%, 81.5%, 61.2%, 95.4% respectively, and that of MRSA was 4.9%, 56.2%, 58%, 31%, 89.8% respectively. Conclusion: Antimicrobial sensitivity to ciprofloxacin, gentamicin, clindamycin, erythromycin, and tetracycline were significantly higher in MSSA than in MRSA.
Read full abstract